Article Information
History
- June 25, 2021.
Article Versions
- Version 1 (April 26, 2021 - 11:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jessica Burt1,2,
- Joseph Ouma2,
- Lawrence Lubyayi3,
- Alexander Amone2,
- Lorna Aol2,
- Musa Sekikubo4,
- Annettee Nakimuli4,
- Eve Nakabembe4,
- Robert Mboizi2,
- Philippa Musoke2,
- Mary Kyohere2,
- Emily Namara2,
- Asma Khalil5 and
- Kirsty Le Doare3,5,*
- 1School of Medicine, University of Leeds, Leeds, UK
- 2Makerere University Johns Hopkins University, Kampala, Uganda
- 3Maternal Vaccines Programme, Medical Research Council/Uganda Virus Research Institute at the London School of Hygiene and Tropical Medicine, Entebbe, Uganda
- 4Department of Obstetrics and Gynaecology, Makerere University, Kampala, Uganda
- 5Infection and Immunity, St. George’s, University of London, London, UK
- ↵*Corresponding author:
Name: Kirsty Le Doare, Postal address: MRC/UVRI@LSHTM Uganda Research Unit, Entebbe, Uganda, Email: kiledoar{at}sgul.ac.uk